Patient Preferences for Attributes of Biologic Treatments in Moderate to Severe Asthma: A Discrete Choice Experiment Study.

Yang, Min; Chao, Jingdong; Fillbrunn, Mirko; Mallya, Usha G; Wang, Min-Jung; Franke, Leigh; Cohn, Lauren; Kamat, Siddhesh

Yang, Min; Chao, Jingdong; Fillbrunn, Mirko; Mallya, Usha G; Wang, Min-Jung; Franke, Leigh; Cohn, Lauren; Kamat, Siddhesh.

Affiliation

Yang M; Analysis Group, Inc, Boston, MA, USA.
Chao J; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.
Fillbrunn M; Analysis Group, Inc, Boston, MA, USA.
Mallya UG; Sanofi, Boston, MA, USA.
Wang MJ; Analysis Group, Inc, Boston, MA, USA.
Franke L; Analysis Group, Inc, Boston, MA, USA.
Cohn L; Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Kamat S; VA Connecticut Healthcare System, West Haven, CT, USA.

Patient Prefer Adherence ; 16: 2649-2661, 2022.

Article in En | MEDLINE | ID: mdl-36176349

Key words

asthma; biologic; patient preference; treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Aspects: Patient_preference Language: En Journal: Patient Prefer Adherence Year: 2022 Document type: Article Affiliation country: United States Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google